Hologic Inc (HOLX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Hologic Inc (HOLX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011735
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic offers its products and services through a network of direct sales and service forces and through independent distributors and sales representatives. The company operates in the Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic Inc (HOLX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Hologic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Hologic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Hologic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Hologic Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Hologic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Hologic Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 12
Private Equity 13
Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 13
Partnerships 14
MeVis Medical Enters into Licensing Agreement with Hologic 14
Microsulis Medical Enters Into Licensing Agreement With Hologic 15
Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 16
Seegene Enters into Agreement with Hologic 17
U.S. Department of Health and Human Services Enters into Agreement with Hologic 18
Bovie Medical Enters into Agreement with Hologic 19
Metamark Genetics Enters into Distribution Agreement with Hologic 20
Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 21
Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 22
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 23
Debt Offering 24
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 24
Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 25
Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion 26
Asset Transactions 27
Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 27
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 29
Atossa Genetics Acquires Rights to Microcatheter System from Hologic 31
Acquisition 32
Hologic Acquires Cynosure in Tender Offer 32
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 34
Hologic Acquires Beijing Healthcome For Up To US$17 Million 36
Hologic Acquires TCT International 37
Hologic Acquires Interlace Medical 38
Hologic Inc – Key Competitors 40
Hologic Inc – Key Employees 41
Hologic Inc – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Affiliate 44
Recent Developments 45
Financial Announcements 45
Nov 08, 2017: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 45
Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 47
May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 49
Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 50
Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 52
Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016 54
Apr 27, 2016: Hologic Announces Financial Results for Second Quarter of Fiscal 2016 56
Jan 27, 2016: Hologic Announces Financial Results for First Quarter of Fiscal 2016 57
Corporate Communications 59
May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 59
Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 60
Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors 61
Mar 02, 2016: Chris Coughlin Elected to Hologic Board of Directors 62
Legal and Regulatory 63
Jan 19, 2016: Hologic’s Tepnel Pharma Services Achieves ISO 17025 Accreditation for Extraction and Genotyping Services 63
Product News 64
Jun 29, 2017: Hologic’s New Panther Fusion System, Flu and Respiratory Assays Now CE Marked in Europe 64
Mar 01, 2017: Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 65
Nov 25, 2016: Hologic to Showcase Award-Winning Breast Screening and Interventional Solutions at RSNA 2016 66
01/06/2016: Metamark Genetics to Serve as Exclusive Sales Agent for Hologic’s Proprietary Prostate Cancer Test 67
Other Significant Developments 68
Aug 09, 2016: HHS awards $4.1 Million to Hologic to Develop better Zika Blood Screening Test 68
Jul 21, 2016: Bovie Medical Announces Sales Channel Partnership Agreement with Hologic for J-Plasma 69
Appendix 70
Methodology 70
About GlobalData 70
Contact Us 70
Disclaimer 70

List of Tables
Hologic Inc, Medical Equipment, Key Facts, 2016 2
Hologic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Hologic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Hologic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Hologic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Hologic Inc, Deals By Market, 2011 to YTD 2017 9
Hologic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 12
Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 13
MeVis Medical Enters into Licensing Agreement with Hologic 14
Microsulis Medical Enters Into Licensing Agreement With Hologic 15
Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 16
Seegene Enters into Agreement with Hologic 17
U.S. Department of Health and Human Services Enters into Agreement with Hologic 18
Bovie Medical Enters into Agreement with Hologic 19
Metamark Genetics Enters into Distribution Agreement with Hologic 20
Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 21
Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 22
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 23
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 24
Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 25
Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion 26
Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 27
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 29
Atossa Genetics Acquires Rights to Microcatheter System from Hologic 31
Hologic Acquires Cynosure in Tender Offer 32
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 34
Hologic Acquires Beijing Healthcome For Up To US$17 Million 36
Hologic Acquires TCT International 37
Hologic Acquires Interlace Medical 38
Hologic Inc, Key Competitors 40
Hologic Inc, Key Employees 41
Hologic Inc, Other Locations 42
Hologic Inc, Subsidiaries 42
Hologic Inc, Affiliate 44

★海外企業調査レポート[Hologic Inc (HOLX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Align Technology, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Align Technology, Inc. Mergers …
  • Okura Industrial Co., Ltd. (4221):企業財務及び戦略的SWOT分析
    Summary Okura Industrial Co., Ltd. (Okura) is a chemical company that manufactures and markets plastic wrapping films, housing products and materials for electronic devices. The company’s plastic wrapping films include industrial materials and general products, laminated products, shrink film, liqui …
  • Cal-Comp Electronics (Thailand) Public Company Limited (CCET):企業概要、財務及び戦略的SWOT分析
    Summary Cal-Comp Electronics (Thailand) Public Company Limited (Cal-Comp) is an electronic product manufacturing company. The company manufactures and markets a range of electronic equipment and products to various markets. Its products include 3D printers, storage products, network attached storage …
  • Six Apart, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Six Apart, Ltd. Mergers and Acq …
  • ERG Spolka Akcyjna (ERG):企業財務及び戦略的SWOT分析
    Summary ERG Spolka Akcyjna (ERG) formerly ZTS Zabkowice - ERG SA is a chemical company that offers production of various kinds of packaging and thermo shrinkable films. The company offers film products, injection products and adhesive tapes. Its film products comprise film for packing frozen food ar …
  • Medtronic Advanced Energy:(医療機器分野)企業M&A及び提携動向
    Summary Medtronic Advanced Energy (MAE) is a medical device company. The company manufactures, develops, markets and sells advanced energy devices used in surgical procedures. It offers products through divisions such as aquamantys products and PEAK plasmablade products. MAE’s products include ablat …
  • Avivagen Inc. (VIV):企業概要、財務及び戦略的SWOT分析
    Summary Avivagen Inc. (Avivagen) is an animal healthcare product company. The company develops science-based, natural health products for animals. It operates through divisions such as companion animal health, food animal health and human health. The company’s products include OxC-beta and Oximunol. …
  • Diaverum Sverige AB (formerly Gambro Healthcare):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Diaverum Sverige AB (formerly G …
  • Capsalus Corp. (Formerly Mach One Corporation):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Capsalus Corp. (Formerly Mach O …
  • NTT Communications Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NTT Communications Corporation …
  • Sunrise Berhad:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sunrise Berhad Mergers and Acqu …
  • Microvision, Inc. (MVIS):企業のM&A・提携動向(医療機器分野)
    Summary Microvision, Inc. (Microvision) is a technology provider that offers new generation of display technology. The company’s display technology is a solution that displays images from a projector with a laser scan beam methodology that uses a single beam of light to project still or moving image …
  • Public Service Enterprise Group Inc:発電所・企業SWOT分析
    Public Service Enterprise Group Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Iberdrola SA (IBE)-エネルギー分野:企業M&A・提携分析
    Summary Iberdrola, S.A. (Iberdrola) is an electric utility. The company generates, trades, transmits, distributes and markets electricity and gas. It operates hydroelectric, thermal and nuclear power plants in Spain and other countries. The company also involved in the production of electricity from …
  • North Energy ASA (NORTH):企業のM&A・提携動向(石油・ガス分野)
    Summary North Energy ASA (North Energy) is an upstream oil and gas company that provides exploration and development activities in Norwegian Continental Shelf (NCS). The company’s business includes license mapping and drilling programmes. It enhances its production activity and expands its acreage p …
  • Duke Energy Florida, Inc.:企業のM&A・提携動向(エネルギー分野)
    Summary Duke Energy Florida, Inc. (Duke Energy Florida), formerly Progress Energy Florida, Inc., a subsidiary of Duke Energy Corporation, is a regulated public utility company. It carries out activities related to generation, transmission, distribution and sale of electricity in Florida. The company …
  • The Williams Companies, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Williams Companies, Inc. Me …
  • Lamar Advertising Company:企業の戦略・SWOT・財務分析
    Lamar Advertising Company - Strategy, SWOT and Corporate Finance Report Summary Lamar Advertising Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Bristol-Myers Squibb Co (BMY)-医療機器分野:企業M&A・提携分析
    Summary Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases. Its primary focus is in cancer, cardiovascular, immunoscience and …
  • SGL Carbon SE:企業の戦略・SWOT・財務分析
    SummarySGL Carbon SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆